December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
The Role Of Myocilin In Fluid Flow Across Cultured Human Trabecular Meshwork And Schlemm's Canal Cells
Author Affiliations & Notes
  • OC Ong
    Department of Ophthalmology UCSF San Francisco CA
  • L Franse-Carman
    Department of Ophthalmology UCSF San Francisco CA
  • DL Epstein
    Department of Ophthalmology Duke University Medical Center Durham NC
  • T Borrás
    Department of Ophthalmology Duke University Medical Center Durham NC
  • JA Alvarado
    Department of Ophthalmology UCSF San Francisco CA
  • Footnotes
    Commercial Relationships   O.C. Ong, None; L. Franse-Carman, None; D.L. Epstein, None; T. Borrás, None; J.A. Alvarado, None. Grant Identification: NIH Grant EY11906
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 4026. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      OC Ong, L Franse-Carman, DL Epstein, T Borrás, JA Alvarado; The Role Of Myocilin In Fluid Flow Across Cultured Human Trabecular Meshwork And Schlemm's Canal Cells . Invest. Ophthalmol. Vis. Sci. 2002;43(13):4026.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose:Most cases of glaucoma are associated with an elevated intraocular pressure which is due to an increased resistance encountered by aqueous humor outflow. The outflow pathway includes cellular barriers composed of trabecular meshwork (TM) cells and schlemm's canal endothelial (SCE) cells. To investigate whether the myocilin gene contributes to the regulation of the barrier properties of human TM and SCE cells, we have overexpressed in both cell types the wild-type human myocilin protein and measured directly the flow resistance of each cell type. Methods:Confluent monolayers of human TM or SCE cells grown on a porous filter support or in a six well plate were transduced with replication deficient recombinant adenovirus containing the full coding cDNA of the human wild-type myocilin gene driven by the cytomegalovirus promoter (AdhTIG3). The flow across the TM or SCE cells in vitro was measured directly and the flow resistance determined. Results:Western blot analysis of the AdhTIG3 transduced TM cells showed overexpression of the 55-57 kDa myocilin protein. Measurement of fluid flow across the cultured TM cells revealed a ten fold decrease in fluid flow resistance in the myocilin transduced cells compared to controls (which consisted of cells transduced with viral vehicles and cells that were not transduced). In contrast, overexpression of the myocilin gene in SCE cells did not result in a change in the fluid flow resistance. Conclusion:These findings suggest that the function of myocilin is cell type dependent. While it has no effect on the barrier properties of the SCE cells, it plays a major role in facilitating transendothelial fluid flow across monolayers of human TM cells. The role of SCE cells as a cellular barrier is accepted by most investigators. However, how TM cells might function as a barrier is not so apparent. Thus it seems surprising that we did not observe a myocilin mediated effect on barrier properties of SCE cells. However these findings are similar to others obtained by using organ cultures transduced with AdhTIG3 (T. B., J Glaucoma 10, 329-39, 2001). Transduction of mutated constructs of myocilin in TM and SCE cells will be important to further investigate myocilin's role in the cellular barrier functions in these two cell types.

Keywords: 503 outflow: trabecular meshwork • 307 adenovirus • 417 gene/expression 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×